Who owns YS BIOPHARMA CO LTD?

Tip: Access positions for across all investors

Analyze quarterly positions in Ys Biopharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Ys Biopharma stock

Who bought or sold YS BIOPHARMA CO LTD this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Millennium Management 1.1M $30k 0% Dec 2023
 View chart
LMR Partners 1.1M $40k 0% Dec 2023
 View chart
Valliance Asset Management 750k $29k 0% Dec 2023
 View chart
BFAM Partners 550k $15k 0% Dec 2023
 View chart
Highbridge Capital Management 539k $11M 0% Dec 2023
 View chart
Jane Street 498k $19k 0% Dec 2023
 View chart
Bracebridge Capital 232k $8.8k 0% Dec 2023
 View chart
Cowen And Company 200k $7.6k 0% Dec 2023
 View chart
Calamos Advisors 146k $4.0k 0% Dec 2023
 View chart
Whitebox Advisors 125k $4.8k 0% Dec 2023
 View chart
D. E. Shaw & Co 100k $2.7k 0% Dec 2023
 View chart
Walleye Trading Advisors 100k $3.8k 0% Dec 2023
 View chart
Saba Capital Management 97k $3.2k 0% Dec 2023
 View chart
Cantor Fitzgerald, L. P. 77k $2.9k 0% Dec 2023
 View chart
Deutsche Bank Aktiengesellschaft 75k $3.0k 0% Dec 2023
 View chart
Exos TFP Holdings 50k $1.9k -49% Dec 2023
 View chart
BosValen Asset Management 39k $1.5k 0% Dec 2023
 View chart
Elequin Capital 38k $1.4k 0% Dec 2023
 View chart
SkyView Investment Advisors 12k $0 0% Dec 2023
 View chart
Ancora Advisors 5.1k $191.900000 0% Dec 2023
 View chart
HGC Investment Management 5.0k $190.000000 0% Dec 2023
 View chart
Wolverine Asset Management 1.2k $45.000000 100% Dec 2023
 View chart

Who sold out of Ys Biopharma?

Fund or Company Name Date Sold Shares Held Valued At
Ionic Capital Management Sep 2023 273k $11k
CNH Partners Sep 2023 43k $1.5k